JBC Advanced Peptides, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M405947200 on December 3, 2004 Originally published In Press as doi:10.1074/jbc.M405947200 on November 4, 2004

J. Biol. Chem., Vol. 280, Issue 3, 1740-1745, January 21, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/3/1740    most recent
M405947200v2
M405947200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burwick, N. R.
Right arrow Articles by Pizzo, S. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burwick, N. R.
Right arrow Articles by Pizzo, S. V.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

An Inhibitor of the F1 Subunit of ATP Synthase (IF1) Modulates the Activity of Angiostatin on the Endothelial Cell Surface*

Nick R. Burwick{ddagger}§, Miriam L. Wahl{ddagger}§, Jun Fang{ddagger}, Zhaoxi Zhong{ddagger}, Tammy L. Moser¶, Bo Li{ddagger}, Roderick A. Capaldi||, Daniel J. Kenan{ddagger}, and Salvatore V. Pizzo{ddagger}**

From the {ddagger}Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710, Departments of Medicine, Microbiology, and Immunology, University of North Carolina, Chapel Hill, North Carolina 27514, and ||Department of Biology and Institute of Molecular Biology, University of Oregon, Eugene, Oregon 97403

Angiostatin binds to endothelial cell (EC) surface F1-F0 ATP synthase, leading to inhibition of EC migration and proliferation during tumor angiogenesis. This has led to a search for angiostatin mimetics specific for this enzyme. A naturally occurring protein that binds to the F1 subunit of ATP synthase and blocks ATP hydrolysis in mitochondria is inhibitor of F1 (IF1). The present study explores the effect of IF1 on cell surface ATP synthase. IF1 protein bound to purified F1 ATP synthase and inhibited F1-dependent ATP hydrolysis consistent with its reported activity in studies of mitochondria. Although exogenous IF1 did not inhibit ATP production on the surface of EC, it did conserve ATP on the cell surface, particularly at low extracellular pH. IF1 inhibited ATP hydrolysis but not ATP synthesis, in contrast to angiostatin, which inhibited both. In cell-based assays used to model angiogenesis in vitro, IF1 did not inhibit EC differentiation to form tubes and only slightly inhibited cell proliferation compared with angiostatin. From these data, we conclude that inhibition of ATP synthesis is necessary for an anti-angiogenic outcome in cell-based assays. We propose that IF1 is not an angiostatin mimetic, but it can serve a protective role for EC in the tumor microenvironment. This protection may be overridden in a concentration-dependent manner by angiostatin. In support of this hypothesis, we demonstrate that angiostatin blocks IF1 binding to ATP synthase and abolishes its ability to conserve ATP. These data suggest that there is a relationship between the binding sites of IF1 and angiostatin on ATP synthase and that IF1 could be employed to modulate angiogenesis.


Received for publication, May 27, 2004 , and in revised form, November 1, 2004.

* This work was supported in part by a NIGMS, National Institutes of Health research grant (to N. R. B.), NCI, National Institutes of Health Grants CA-56690 (to M. L. W.), CA86344 (to S. V. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ These authors contributed equally to this study.

** To whom correspondence should be addressed: Dept. of Pathology, Box 3712, Duke University Medical Center, Durham, NC 27710. Tel.: 919-684-3528; Fax: 919-684-8689; E-mail: Pizzo001{at}mc.duke.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
J. A. Mennigen, C. J. Martyniuk, K. Crump, H. Xiong, E. Zhao, J. Popesku, H. Anisman, A. R. Cossins, X. Xia, and V. L. Trudeau
Effects of fluoxetine on the reproductive axis of female goldfish (Carassius auratus)
Physiol Genomics, November 1, 2008; 35(3): 273 - 282.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. L. Chi, M. L. Wahl, Y. M. Mowery, S. Shan, S. Mukhopadhyay, S. C. Hilderbrand, D. J. Kenan, B. D. Lipes, C. E. Johnson, M. F. Marusich, et al.
Angiostatin-Like Activity of a Monoclonal Antibody to the Catalytic Subunit of F1F0 ATP Synthase
Cancer Res., May 15, 2007; 67(10): 4716 - 4724.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. L. Chi and S. V. Pizzo
Angiostatin Is Directly Cytotoxic to Tumor Cells at Low Extracellular pH: A Mechanism Dependent on Cell Surface-Associated ATP Synthase
Cancer Res., January 15, 2006; 66(2): 875 - 882.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.